Connection

KEITH WEBSTER to Recombinant Fusion Proteins

This is a "connection" page, showing publications KEITH WEBSTER has written about Recombinant Fusion Proteins.
Connection Strength

0.129
  1. Suppression of matrigel-induced choroidal neovascularization by AAV delivery of a novel anti-Scg3 antibody. Gene Ther. 2024 Nov; 31(11-12):587-593.
    View in: PubMed
    Score: 0.044
  2. Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy. Cell Mol Life Sci. 2022 Jan 10; 79(1):63.
    View in: PubMed
    Score: 0.037
  3. Selectively targeting disease-restricted secretogranin III to alleviate choroidal neovascularization. FASEB J. 2022 01; 36(1):e22106.
    View in: PubMed
    Score: 0.037
  4. Enhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein. Mol Cancer Ther. 2005 Jun; 4(6):956-67.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.